Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
4.760
-0.230 (-4.61%)
At close: Apr 28, 2026, 4:00 PM EDT
4.730
-0.030 (-0.63%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Atara Biotherapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Sell
Price Target
$5.00
Upside
+5.04%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Freedom Broker | Freedom Broker | Strong Buy → Strong Sell Downgrades $16 → $4 | Strong Buy → Strong Sell | Downgrades | $16 → $4 | -15.97% | Jan 21, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $25 → $6 | Strong Buy → Hold | Downgrades | $25 → $6 | +26.05% | Jan 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 → $25 | Strong Buy | Maintains | $17 → $25 | +425.21% | Dec 19, 2025 |
| Freedom Broker | Freedom Broker | Strong Sell Maintains $13 → $16 | Strong Sell | Maintains | $13 → $16 | +236.13% | Jul 28, 2025 |
| Freedom Broker | Freedom Broker | Strong Sell Maintains $11 → $13 | Strong Sell | Maintains | $11 → $13 | +173.11% | May 23, 2025 |
| Freedom Broker | Freedom Broker | Strong Sell Maintains $13 → $11 | Strong Sell | Maintains | $13 → $11 | +131.09% | Mar 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +257.14% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 22, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $21 → $17 | Strong Buy | Maintains | $21 → $17 | +257.14% | Jan 17, 2025 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +425.21% | Dec 20, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $21 | Strong Buy | Maintains | $13 → $21 | +341.18% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 21, 2024 |
| Mizuho | Mizuho | Hold → Buy Upgrades $25 → $18 | Hold → Buy | Upgrades | $25 → $18 | +278.15% | Aug 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +173.11% | Aug 13, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $13 → $11 | Strong Sell | Maintains | $13 → $11 | +131.09% | Jul 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.